Skip to main content
Premium Trial:

Request an Annual Quote

Indiana Protein Center Signs First Clients, Receives Grants

NEW YORK, Aug. 24 (GenomeWeb News) - The Indiana Centers for Applied Protein Sciences, a for-profit venture that provides contract proteomic technology validation and protein analysis services, said yesterday that it has signed its first round of client agreements and that it has received two grants.

 

According to INCAPS, it now has committed projects from Eli Lilly, Dow AgroSciences and the Indiana University School of Medicine and is in varying stages of project development with several clients, including PurdueUniversity; IndianaUniversity, Bloomington; and the Lilly, IndianaUniversity, and Purdue research alliance Inproteo.

 

The first grant, worth $2 million, is from the State of Indiana's 21st Century Research and Technology Fund to defray start-up costs. The second, worth $400,000, is from the Indiana Department of Commerce and will allow INCAPS to purchase scientific equipment.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.